Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1992-4-1
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0706-7437
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
764-5
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:1686420-Anti-Anxiety Agents,
pubmed-meshheading:1686420-Benzodiazepines,
pubmed-meshheading:1686420-Canada,
pubmed-meshheading:1686420-Cross-Sectional Studies,
pubmed-meshheading:1686420-Humans,
pubmed-meshheading:1686420-Incidence,
pubmed-meshheading:1686420-Substance Withdrawal Syndrome,
pubmed-meshheading:1686420-Substance-Related Disorders
|
pubmed:year |
1991
|
pubmed:articleTitle |
Increase in benzodiazepine abuse.
|
pubmed:publicationType |
Letter,
Comment
|